With 44.68M Outstanding Shares, Can Cardiff Oncology Inc (NASDAQ: CRDF) Deliver Big Short-Term Gains?

Cardiff Oncology Inc (NASDAQ:CRDF) currently has a daily average trading volume of 1.67M but it saw 1884514 shares traded in last market. With a market cap of 253.34M USD, the company’s current market price of $5.67 came rising about 6.38 while comparing to the previous closing price of $5.33. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.42 and as low as $0.94.

Taking a look at 20-day trading activity of Cardiff Oncology Inc (CRDF) gives us an average price of $5.12, while its current price level is -11.68% below from 52-week high level whereas it is 503.19% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $3.20 while that of 200 days or SMA-200 reads an average of $1.90. A closer look into the stock’s movement over the week reveals that its volatility is standing at 10.98% during that period while stretching the period over a month that increases to 15.79%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 64.48 which implies that the stock is in neutral territory.

Maxim Group issued its recommendations for the stock as it resumed the price target for the stock in the range of between $30 and $20.

Over the week, CRDF’s stock price is moving -1.39% down while it is 55.34% when we observe its performance for the past one month. Year-to-date it is 283.11% up and over the past year, the stock is showing an upside performance of 252.17%.

Currently, Cardiff Oncology Inc’s total number of outstanding shares is 44.68M with 7.56% of that held by the insiders while 15.17% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -58.24% and return on equity (ROE) at -47.07%. Stock’s beta reads 1.97. Stock has a price to book (P/B) ratio of 3.63 while price to sale or P/S ratio amounts to 517.01. Its return on asset (ROA) is -41.90% on average.